Improved Survival of Children with Sepsis and Purpura: Effects of Age, Gender, and Era

Overview

Journal Crit Care

Specialty Critical Care

Date 2007 Oct 20

PMID 17945008

Citations 16

Authors

Martine Maat

Corinne M P Buysse

Marieke Emonts

Lodewijk Spanjaard

Koen F M Joosten

Ronald de Groot

Jan A Hazelzet

Affiliations

Soon will be listed here.

Abstract

Background: To gain insight into factors that might affect results of future case-control studies, we performed an analysis of children with sepsis and purpura admitted to the paediatric intensive care unit (PICU) of Erasmus MC-Sophia Children's Hospital (Rotterdam, The Netherlands).

Methods: Between 1988 and 2006, all 287 children consecutively admitted with sepsis and purpura were included in various sepsis studies. Data regarding age, gender, ethnicity, serogroup of Neisseria meningitidis, severity, therapy, and survival were collected prospectively. These data were pooled into one database and analyzed retrospectively.

Results: The case fatality rate (CFR) from sepsis and purpura was 15.7%. During the study period, survival improved significantly. Younger age was significantly associated with more severe disease and a higher CFR. Children under the median age of 3.0 years had an increased risk of case fatality (odds ratio 4.3, 95% confidence interval 2.1 to 9.2; p < 0.001). Gender was not associated with CFR. However, males did have higher Paediatric Risk of Mortality scores, fewer PICU-free days, and more presence of shock. The course of sepsis and purpura was not related to ethnic origin. A causative organism was isolated in 84.3% of cases. N. meningitidis was the major organism (97.5%). Although N. meningitidis serogroup B was observed more often in younger children, serogroups were not associated with severity or survival. During the study period, the use of inotropic agents and corticosteroids changed substantially (less dopamine and more dobutamine, norepinephrine, and corticosteroids).

Conclusion: Age and gender are determinants of severity of paediatric sepsis and purpura. Survival rates have improved during the last two decades.

Citing Articles

Criteria for Pediatric Sepsis-A Systematic Review and Meta-Analysis by the Pediatric Sepsis Definition Taskforce.

Menon K, Schlapbach L, Akech S, Argent A, Biban P, Carrol E Crit Care Med. 2021; 50(1):21-36.

PMID: 34612847 PMC: 8670345. DOI: 10.1097/CCM.0000000000005294.

Factors associated with death in children with purpura fulminans: a French national prospective cohort study.

Madhi F, Ouldali N, Levy C, Taha M, Cohen R Crit Care. 2021; 25(1):181.

PMID: 34049571 PMC: 8164283. DOI: 10.1186/s13054-021-03603-8.

Transcriptomic markers in pediatric septic shock prognosis: an integrative analysis of gene expression profiles.

Wang Q, Huang J, Chen X, Wang J, Fang F Braz J Med Biol Res. 2021; 54(3):e10152.

PMID: 33503200 PMC: 7836399. DOI: 10.1590/1414-431X202010152.

Long noncoding RNA and messenger RNA abnormalities in pediatric sepsis: a preliminary study.

Bai Z, Li Y, Li Y, Pan J, Wang J, Fang F BMC Med Genomics. 2020; 13(1):36.

PMID: 32151258 PMC: 7063742. DOI: 10.1186/s12920-020-0698-x.

Clinical spectrum and short-term outcome of adult patients with purpura fulminans: a French multicenter retrospective cohort study.

Contou D, Sonneville R, Canoui-Poitrine F, Colin G, Coudroy R, Pene F Intensive Care Med. 2018; 44(9):1502-1511.

PMID: 30128591 DOI: 10.1007/s00134-018-5341-3.

References

Emonts M, Hazelzet J, de Groot R, Hermans P . Host genetic determinants of Neisseria meningitidis infections. Lancet Infect Dis. 2003; 3(9):565-77. DOI: 10.1016/s1473-3099(03)00740-0. View

Zuppa A, Nadkarni V, Davis L, Adamson P, Helfaer M, Elliott M . The effect of a thyroid hormone infusion on vasopressor support in critically ill children with cessation of neurologic function. Crit Care Med. 2005; 32(11):2318-22. DOI: 10.1097/01.ccm.0000146133.52982.17. View

de Kleijn E, de Groot R, Hack C, Mulder P, Engl W, Moritz B . Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study. Crit Care Med. 2003; 31(6):1839-47. DOI: 10.1097/01.CCM.0000072121.61120.D8. View

Taylor Jr F, Toh C, Hoots W, Wada H, Levi M . Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2002; 86(5):1327-30. View

Cohen J . The immunopathogenesis of sepsis. Nature. 2002; 420(6917):885-91. DOI: 10.1038/nature01326. View

Goldstein B, Giroir B, Randolph A . International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005; 6(1):2-8. DOI: 10.1097/01.PCC.0000149131.72248.E6. View

Sharip A, Sorvillo F, Redelings M, Mascola L, Wise M, Nguyen D . Population-based analysis of meningococcal disease mortality in the United States: 1990-2002. Pediatr Infect Dis J. 2006; 25(3):191-4. DOI: 10.1097/01.inf.0000202065.03366.0c. View

Pollack M, Ruttimann U, Getson P . Pediatric risk of mortality (PRISM) score. Crit Care Med. 1988; 16(11):1110-6. DOI: 10.1097/00003246-198811000-00006. View

Kornelisse R, Hazelzet J, Hop W, Spanjaard L, Suur M, van der Voort E . Meningococcal septic shock in children: clinical and laboratory features, outcome, and development of a prognostic score. Clin Infect Dis. 1997; 25(3):640-6. DOI: 10.1086/513759. View

10.

van Deuren M, Brandtzaeg P, van der Meer J . Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev. 2000; 13(1):144-66, table of contents. PMC: 88937. DOI: 10.1128/CMR.13.1.144. View

11.

van der Ende A, Schuurman I, Hopman C, Fijen C, Dankert J . Comparison of commercial diagnostic tests for identification of serogroup antigens of Neisseria meningitidis. J Clin Microbiol. 1995; 33(12):3326-7. PMC: 228700. DOI: 10.1128/jcm.33.12.3326-3327.1995. View

12.

den Brinker M, Joosten K, Liem O, de Jong F, Hop W, Hazelzet J . Adrenal insufficiency in meningococcal sepsis: bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality. J Clin Endocrinol Metab. 2005; 90(9):5110-7. DOI: 10.1210/jc.2005-1107. View

13.

de Groof F, Joosten K, Janssen J, de Kleijn E, Hazelzet J, Hop W . Acute stress response in children with meningococcal sepsis: important differences in the growth hormone/insulin-like growth factor I axis between nonsurvivors and survivors. J Clin Endocrinol Metab. 2002; 87(7):3118-24. DOI: 10.1210/jcem.87.7.8605. View

14.

Watson R, Carcillo J, Linde-Zwirble W, Clermont G, Lidicker J, Angus D . The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med. 2002; 167(5):695-701. DOI: 10.1164/rccm.200207-682OC. View

15.

Bouwhuis C, Moll H . Determination of ethnicity in children in The Netherlands: two methods compared. Eur J Epidemiol. 2003; 18(5):385-8. DOI: 10.1023/a:1024205226239. View

16.

Rosenstein N, Perkins B, Stephens D, Popovic T, Hughes J . Meningococcal disease. N Engl J Med. 2001; 344(18):1378-88. DOI: 10.1056/NEJM200105033441807. View

17.

Derkx B, Wittes J, McCloskey R . Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. European Pediatric Meningococcal Septic Shock Trial Study Group. Clin Infect Dis. 2000; 28(4):770-7. DOI: 10.1086/515184. View

18.

Booy R, Habibi P, Nadel S, de Munter C, Britto J, Morrison A . Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery. Arch Dis Child. 2001; 85(5):386-90. PMC: 1718959. DOI: 10.1136/adc.85.5.386. View

19.

Bindl L, Buderus S, Dahlem P, Demirakca S, Goldner M, Huth R . Gender-based differences in children with sepsis and ARDS: the ESPNIC ARDS Database Group. Intensive Care Med. 2003; 29(10):1770-3. DOI: 10.1007/s00134-003-1948-z. View

20.

van der Kaay D, de Kleijn E, de Rijke Y, Hop W, de Groot R, Hazelzet J . Procalcitonin as a prognostic marker in meningococcal disease. Intensive Care Med. 2002; 28(11):1606-12. DOI: 10.1007/s00134-002-1505-1. View